SilverCloud raises $8.1m from VC firm

Digital health company SilverCloud Health has announced that it has raised $8.1 million in Series A funding.Read more


Metabolomic Diagnostics secures €1.6M investment

DC 16/06/2016 - REPRO FREE FREE PIC Irish biotech company, Metabolomic Diagnostics, has secured a further €2 million in venture funding to help complete PrePsia, its pre-eclampsia screening test for first time pregnant mothers.  Pictured here with 4 day old baby Molly, are Frank Walsh, Partner, Enterprise Equity, Bill Liao, European Investment Partner, SOSventures, Charles Garvey, CEO, Metabolomic Diagnostics, and Prof. Louise Kenny, Consultant Obstetrician at CUMH & Director of the INFANT Centre. Pic: Diane Cusack
Frank Walsh, Partner, Enterprise Equity, Bill Liao, European Investment Partner, SOSventures, Charles Garvey, CEO, Metabolomic Diagnostics, and Prof. Louise Kenny, Consultant Obstetrician at CUMH & Director of the INFANT Centre.

Irish biotech company, Metabolomic Diagnostics, has secured an additional €1.6 million from investors to help complete PrePsia™, its new screening test for pre-eclampsia in first time pregnant mothers. Read more


Beverly Hills
9750 Shire Boulevard, Suite 450Beverly Hills, CA 90212
Dubai
Al Fattan Crystal TowersDubai Marina, Sheikh Zayed Road
Contact
contact@yoursite.com+39 (0)215 770 0521

Mason

Privacy Preference Center